|
Status |
Public on Nov 13, 2019 |
Title |
Importance of AMPK in metformin suppression of liver glucose production |
Organism |
Mus musculus |
Experiment type |
Expression profiling by array
|
Summary |
Metformin is now the most widely prescribed oral anti-diabetic agent worldwide, taken by over 150 million people annually. Although metformin has been used clinically to treat type 2 diabetes for over 60 years. Its mechanism of action remains only partially understood and controversial. In particular, this includes whether AMPK plays a role in metformin suppression of liver glucose production. To address this issue, we knocked out the AMPK catalytic alpha1 and alpha 2 subunits in the liver of HFD-fed adult homozygous mice. These mice were treated with a physiological relevent metformin dose (50 mg/kg/day) for 3 weeks. Liver samples were collected.
|
|
|
Overall design |
6 weeks old male floxed homozygous AMPK alpha1/2 mice were fed an HFD for 4 weeks, AAV8-TBG-E.V. and AAV8-TBG-Cre (1X10^11GC/mouse) were injected via jugular vein, and mice were treated with metformin (50 mg/kg/day) for 3 weeks, liver samples were collected after 16 h fast. There are 14 samples, 6 samples from control group (WT), another 8 samples from treated group (Cre KO).
|
|
|
Contributor(s) |
He L |
Citation(s) |
31693892 |
|
Submission date |
May 09, 2018 |
Last update date |
Nov 13, 2019 |
Contact name |
Ling He |
Organization name |
The Johns Hopkins University School of Medicine
|
Department |
Department of Pediatrics-Division of Endocrinology
|
Street address |
600 North Wolfe St
|
City |
Baltimore |
State/province |
MD |
ZIP/Postal code |
21287 |
Country |
USA |
|
|
Platforms (1) |
GPL23038 |
[Clariom_S_Mouse] Affymetrix Clariom S Assay, Mouse (Includes Pico Assay) |
|
Samples (14)
|
|
Relations |
BioProject |
PRJNA470636 |